- Thinly traded nano cap Titan Pharmaceuticals (TTNP -29%) is down on almost double normal volume, albeit on turnover of only 467K shares, on the heels of its agreement with an institutional investor to sell ~2.9M shares of its common stock plus five-year warrants to purchase up to the same number of shares at $1.07 at a combined price of $0.75.
- Net proceeds should be ~$1.8M.
- Yesterday's close was $1.07.
Titan Pharma down 29% on capital raise
Recommended For You
About TTNP Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
TTNP | - | - |
Titan Pharmaceuticals, Inc. |